Skip to content

Public FDA record

Z-2614-2023: Gallant VR Implantable Cardioverter Defibrillator: VR ICD REF CDVRA500Q Gallant DR Implantable Cardiovert

Recall record Z-2614-2023 for Abbott Medical. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2614-2023
Company in FDA record
Abbott Medical
FDA classification date
Sep 19, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to Bluetooth malfunction on a subset of Implantable Cardioverter Defibrillator (ICD) and Cardia Resynchronization Therapy Defibrillator *CRT-D) devices that were manufactured prior to April 2022 as a result of crystal component issue within the Bluetooth Low Energy (BLE) circuit. This results in the device entering an inductive telemetry only mode with loss of Bluetooth communication. In some instances, thought BLE communication is unavailable, the circuit may remain in a state which draws excessive power affecting battery longevity.

Source facts

Action
On 08/16/2023, the firm sent to U.S. customers an "URGENT MEDICAL DEVICE CORRECTION" Letter (via mail, email or hand-delivery) informing physicians and healthcare professionals that there is a potential for a Bluetooth (BLE) circuit component issue on a subset of Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators manufactured prior to April 2022. The issue is associated with a risk of loss of Bluetooth communication (and therefore a loss of remote monitoring), higher-than-normal current consumption, and reduced device battery longevity. Patient Management Recommendations: 1. Prophylactic device replacement is not recommended as new firmware version pr00.10.87.04 eliminates the potential for loss of therapy between follow-up due to unrecognized decreased device longevity. 2. Determine the firmware version of devices followed at clinics by reviewing the instructions in Appendix A and the device list in Appendix B. 3. Patients with firmware version pr00.10.87.00 or firmware version undetermined, upgrade devices to firmware version pr00.10.87.04: -Prioritize in-clinic firmware upgrade for the specific devices from the 1,500 device sub-group (listed in Appendix B) -For remaining patients, schedule the next follow-up in clinic to complete firmware upgrade. 3. Following firmware upgrade, continue to follow patients routinely 4. If device experience a loss of Bluetooth communication, contact Abbott Technical Support at 1-800-722-3774 (U.S.). In addition, a list of Abbott advisories is available at https://www.cardiovascular.abbott/us/en/hcp/product-advisories.html Abbott has also include a web version of the Customer Notification Letter at https://www.cardiovascular.abbott/content/dam/cv/cardiovascular/pdf/reports/US-Abbott-Communication-BLE-Communication-Final-FDA-v2.pdf
Initiated
2023-08-16
Root cause
Component design/selection
Distribution
U.S.: Nation-wide O.U.S.: Australia, Austria, Bahrain, Belgium, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italy, Korea, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Malaysia, Nepal, Netherlands, New Zealand, Norway, Oman, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates, United Kingdom. Latin America - Pending
Recall number
Z-2614-2023
Recall status
Open, Classified
CDRH record ID
202928
FDA classified
2023-09-19
Recall event number
92923

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗